Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer.

There is no fulltext present in this item.

Title:	Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer.
Author(s):	Witte, J.H. de ; Sweep, C.G.J. ; Klijn, J.G.M.; Grebenchtchikov, N.J. ; Peters, H.A. ; Look, M.P.; Tienoven, T.H. van ; Heuvel, J.J.T.M. ; Bolt-De Vries, J.; Benraad, T.J. ; Foekens, J.A.
Publication year:	1999
Source:	British Journal of Cancer, vol. 80, iss. 1/2, (1999), pp. 286-294
ISSN:	0007-0920
DOI:	https://doi.org/10.1038/sj.bjc.6690353
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/184848
Display more details
Subject:	Development of Quality Assurance programs for prognostic factors in oncological endocrinology Ontwikkeling van kwaliteitscontrole-programma's voor prognostische factoren in de oncologische endocrinologie
Organization:	Chemical Endocrinology
Journal title:	British Journal of Cancer
Volume:	vol. 80
Issue:	iss. 1/2
Page start:	p. 286
Page end:	p. 294